RSS

patient recruitment

International contract development and manufacturing organisation (CDMO), Hovione has announced the enrolment of the first patient in the Phase II clinical trial of its topical minocycline (HY01) in moderate to severe papulopustular rosacea patients. more

News

Biopharmaceutical company, Ablynx, has announced the completion of patient recruitment for its Phase III HERCULES study of caplacizumab for the treatment of acquired thrombotic thrombocytopenic purpura (aTTP). more

News

Expansions to its site alliance network mean biopharma specialist will be able to offer clients faster enrolment times for clinical trials. more

News

All of the 39 investigation sites across seven European countries (Belgium, Finland, France, Germany, the Netherlands, Spain and the UK) are fully operational. more